Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT00091832
Brief Summary:
This study is to evaluate various doses and schedules for denosumab administration and characterize the safety profile in this indication.
Study:
NCT00091832
Study Brief:
Protocol Section:
NCT00091832